Evidence map›Paper›PMID 32357394›Full record

ReviewAntioxidants (Basel, Switzerland)2020

Oxidative Stress-Generating Antimicrobials, a Novel Strategy to Overcome Antibacterial Resistance.

Álvaro Mourenza, José A Gil, Luís M Mateos, Michal Letek

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Review
  5. PFK-158 enhances colistin efficacy against resistantFrontiers in veterinary science · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Álvaro MourenzaDepartamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 - León, Spain.ORCID 0000-0003-4926-3891
José A GilDepartamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 - León, Spain.ORCID 0000-0002-5069-2637
Luís M MateosDepartamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 - León, Spain.ORCID 0000-0001-7763-582X
Michal LetekDepartamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 - León, Spain.ORCID 0000-0002-9509-5174
Universidad de León · ES

Funding

Universidad de León N/AUniversity of Roehampton N/A
6 · The paper itself

Abstract

Antimicrobial resistance is becoming one of the most important human health issues. Accordingly, the research focused on finding new antibiotherapeutic strategies is again becoming a priority for governments and major funding bodies. The development of treatments based on the generation of oxidative stress with the aim to disrupt the redox defenses of bacterial pathogens is an important strategy that has gained interest in recent years. This approach is allowing the identification of antimicrobials with repurposing potential that could be part of combinatorial chemotherapies designed to treat infections caused by recalcitrant bacterial pathogens. In addition, there have been important advances in the identification of novel plant and bacterial secondary metabolites that may generate oxidative stress as part of their antibacterial mechanism of action. Here, we revised the current status of this emerging field, focusing in particular on novel oxidative stress-generating compounds with the potential to treat infections caused by intracellular bacterial pathogens.

Indexed as

antimicrobial resistanceintracellular pathogensoxidative stressreactive oxygen and nitrogen species

Identifiers

PMID32357394
PMCPMC7278815
OpenAlexW3018350130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.